On the relationship between human papilloma virus vaccine and autoimmune diseases

Paolo Pellegrino, Carla Carnovale, Marco Pozzi, Stefania Antoniazzi, Valentina Perrone, Dionigi Salvati, Marta Gentili, Tatiana Brusadelli, Emilio Clementi, Sonia Radice

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

The human papilloma virus (HPV) vaccines were introduced to reduce the incidence of cervical cancer. The bivalent vaccine is effective against HPV-16, -18, -31, -33 and -45 while the quadrivalent vaccine is effective against HPV-16, 18, 31, 6 and 11 types. The immunisation, recommended for adolescent females, has led to high vaccine coverage in many countries.Along with the introduction of the HPV vaccines, several cases of onset or exacerbations of autoimmune diseases following the vaccine shot have been reported in the literature and pharmacovigilance databases, triggering concerns about its safety. This vaccination programme, however, has been introduced in a population that is at high risk for the onset of autoimmune diseases, making it difficult to assess the role of HPV vaccine in these cases and no conclusive studies have been reported thus far.We have thus analysed and reviewed comprehensively all case reports and studies dealing with either the onset of an autoimmune disease in vaccinated subject or the safety in patients with autoimmune diseases to define the role of the HPV vaccines in these diseases and hence its safety. A solid evidence of causal relationship was provided in few cases in the examined studies, and the risk vs. benefit of vaccination is still to be solved. The on-going vigilance for the safety of this vaccine remains thus of paramount importance.

Original languageEnglish
Pages (from-to)736-741
Number of pages6
JournalAutoimmunity Reviews
Volume13
Issue number7
DOIs
Publication statusPublished - 2014

Fingerprint

Papillomavirus Vaccines
Virus Diseases
Autoimmune Diseases
Vaccines
Papillomaviridae
Safety
Vaccination
Pharmacovigilance
Patient Safety
Uterine Cervical Neoplasms
Immunization
Databases
Incidence
Population

Keywords

  • Acute disseminated encephalomyelitis
  • Autoimmunity diseases
  • Human papilloma virus vaccine
  • Juvenile idiopathic arthritis
  • Multiple sclerosis
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Medicine(all)

Cite this

Pellegrino, P., Carnovale, C., Pozzi, M., Antoniazzi, S., Perrone, V., Salvati, D., ... Radice, S. (2014). On the relationship between human papilloma virus vaccine and autoimmune diseases. Autoimmunity Reviews, 13(7), 736-741. https://doi.org/10.1016/j.autrev.2014.01.054

On the relationship between human papilloma virus vaccine and autoimmune diseases. / Pellegrino, Paolo; Carnovale, Carla; Pozzi, Marco; Antoniazzi, Stefania; Perrone, Valentina; Salvati, Dionigi; Gentili, Marta; Brusadelli, Tatiana; Clementi, Emilio; Radice, Sonia.

In: Autoimmunity Reviews, Vol. 13, No. 7, 2014, p. 736-741.

Research output: Contribution to journalArticle

Pellegrino, P, Carnovale, C, Pozzi, M, Antoniazzi, S, Perrone, V, Salvati, D, Gentili, M, Brusadelli, T, Clementi, E & Radice, S 2014, 'On the relationship between human papilloma virus vaccine and autoimmune diseases', Autoimmunity Reviews, vol. 13, no. 7, pp. 736-741. https://doi.org/10.1016/j.autrev.2014.01.054
Pellegrino, Paolo ; Carnovale, Carla ; Pozzi, Marco ; Antoniazzi, Stefania ; Perrone, Valentina ; Salvati, Dionigi ; Gentili, Marta ; Brusadelli, Tatiana ; Clementi, Emilio ; Radice, Sonia. / On the relationship between human papilloma virus vaccine and autoimmune diseases. In: Autoimmunity Reviews. 2014 ; Vol. 13, No. 7. pp. 736-741.
@article{015f596641754d3ab7dfe0e8d31a81f3,
title = "On the relationship between human papilloma virus vaccine and autoimmune diseases",
abstract = "The human papilloma virus (HPV) vaccines were introduced to reduce the incidence of cervical cancer. The bivalent vaccine is effective against HPV-16, -18, -31, -33 and -45 while the quadrivalent vaccine is effective against HPV-16, 18, 31, 6 and 11 types. The immunisation, recommended for adolescent females, has led to high vaccine coverage in many countries.Along with the introduction of the HPV vaccines, several cases of onset or exacerbations of autoimmune diseases following the vaccine shot have been reported in the literature and pharmacovigilance databases, triggering concerns about its safety. This vaccination programme, however, has been introduced in a population that is at high risk for the onset of autoimmune diseases, making it difficult to assess the role of HPV vaccine in these cases and no conclusive studies have been reported thus far.We have thus analysed and reviewed comprehensively all case reports and studies dealing with either the onset of an autoimmune disease in vaccinated subject or the safety in patients with autoimmune diseases to define the role of the HPV vaccines in these diseases and hence its safety. A solid evidence of causal relationship was provided in few cases in the examined studies, and the risk vs. benefit of vaccination is still to be solved. The on-going vigilance for the safety of this vaccine remains thus of paramount importance.",
keywords = "Acute disseminated encephalomyelitis, Autoimmunity diseases, Human papilloma virus vaccine, Juvenile idiopathic arthritis, Multiple sclerosis, Rheumatoid arthritis",
author = "Paolo Pellegrino and Carla Carnovale and Marco Pozzi and Stefania Antoniazzi and Valentina Perrone and Dionigi Salvati and Marta Gentili and Tatiana Brusadelli and Emilio Clementi and Sonia Radice",
year = "2014",
doi = "10.1016/j.autrev.2014.01.054",
language = "English",
volume = "13",
pages = "736--741",
journal = "Autoimmunity Reviews",
issn = "1568-9972",
publisher = "Elsevier",
number = "7",

}

TY - JOUR

T1 - On the relationship between human papilloma virus vaccine and autoimmune diseases

AU - Pellegrino, Paolo

AU - Carnovale, Carla

AU - Pozzi, Marco

AU - Antoniazzi, Stefania

AU - Perrone, Valentina

AU - Salvati, Dionigi

AU - Gentili, Marta

AU - Brusadelli, Tatiana

AU - Clementi, Emilio

AU - Radice, Sonia

PY - 2014

Y1 - 2014

N2 - The human papilloma virus (HPV) vaccines were introduced to reduce the incidence of cervical cancer. The bivalent vaccine is effective against HPV-16, -18, -31, -33 and -45 while the quadrivalent vaccine is effective against HPV-16, 18, 31, 6 and 11 types. The immunisation, recommended for adolescent females, has led to high vaccine coverage in many countries.Along with the introduction of the HPV vaccines, several cases of onset or exacerbations of autoimmune diseases following the vaccine shot have been reported in the literature and pharmacovigilance databases, triggering concerns about its safety. This vaccination programme, however, has been introduced in a population that is at high risk for the onset of autoimmune diseases, making it difficult to assess the role of HPV vaccine in these cases and no conclusive studies have been reported thus far.We have thus analysed and reviewed comprehensively all case reports and studies dealing with either the onset of an autoimmune disease in vaccinated subject or the safety in patients with autoimmune diseases to define the role of the HPV vaccines in these diseases and hence its safety. A solid evidence of causal relationship was provided in few cases in the examined studies, and the risk vs. benefit of vaccination is still to be solved. The on-going vigilance for the safety of this vaccine remains thus of paramount importance.

AB - The human papilloma virus (HPV) vaccines were introduced to reduce the incidence of cervical cancer. The bivalent vaccine is effective against HPV-16, -18, -31, -33 and -45 while the quadrivalent vaccine is effective against HPV-16, 18, 31, 6 and 11 types. The immunisation, recommended for adolescent females, has led to high vaccine coverage in many countries.Along with the introduction of the HPV vaccines, several cases of onset or exacerbations of autoimmune diseases following the vaccine shot have been reported in the literature and pharmacovigilance databases, triggering concerns about its safety. This vaccination programme, however, has been introduced in a population that is at high risk for the onset of autoimmune diseases, making it difficult to assess the role of HPV vaccine in these cases and no conclusive studies have been reported thus far.We have thus analysed and reviewed comprehensively all case reports and studies dealing with either the onset of an autoimmune disease in vaccinated subject or the safety in patients with autoimmune diseases to define the role of the HPV vaccines in these diseases and hence its safety. A solid evidence of causal relationship was provided in few cases in the examined studies, and the risk vs. benefit of vaccination is still to be solved. The on-going vigilance for the safety of this vaccine remains thus of paramount importance.

KW - Acute disseminated encephalomyelitis

KW - Autoimmunity diseases

KW - Human papilloma virus vaccine

KW - Juvenile idiopathic arthritis

KW - Multiple sclerosis

KW - Rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=84898881700&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898881700&partnerID=8YFLogxK

U2 - 10.1016/j.autrev.2014.01.054

DO - 10.1016/j.autrev.2014.01.054

M3 - Article

C2 - 24468416

AN - SCOPUS:84898881700

VL - 13

SP - 736

EP - 741

JO - Autoimmunity Reviews

JF - Autoimmunity Reviews

SN - 1568-9972

IS - 7

ER -